Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
Disease relapse and therapy resistance remain key challenges in treating multiple myeloma. Underlying (epi-)mutational events can promote myelomagenesis and contribute to multi-drug and apoptosis resistance. Therefore, compounds inducing ferroptosis, a form of iron and lipid peroxidation-regulated c...
Guardado en:
Autores principales: | Emilie Logie, Bart Van Puyvelde, Bart Cuypers, Anne Schepers, Herald Berghmans, Jelle Verdonck, Kris Laukens, Lode Godderis, Maarten Dhaenens, Dieter Deforce, Wim Vanden Berghe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/128c5ee5fc334f36a213008aab24613c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: Jacob King, et al.
Publicado: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
por: Tandon N, et al.
Publicado: (2016) -
An Emerging Role for Epigenetics in Cerebral Palsy
por: Brigette Romero, et al.
Publicado: (2021) -
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
por: Norikazu Masuda, et al.
Publicado: (2021) -
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
por: Xuemei Yao, et al.
Publicado: (2021)